Published Wednesday, May 14 2008
Bourne Capital Partners, LLC ("Bourne Partners") through its Canadian subsidiary, Critique Pharmaceuticals Inc., announces the acquisition of the Theramed Corporation ("Theramed"). Theramed is a full-service Canadian medical device, pharmaceutical and biotech commercialization company...
Published Wednesday, April 30 2008
ASHBURN, Va.,April 30, 2008—Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last of three planned phase 2 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx® GENTAMICIN TOPICAL for the treatment and prevention...
Published Wednesday, August 08 2007
ASHBURN, Virginia – Innocoll, Inc. announced its wholly- owned subsidiary, Innocoll Pharmaceuticals Ltd., has received a class IV medical device licence for its CollaRx® GENTAMICIN SURGICAL IMPLANT from the Canadian regulatory authority, Health Canada . Innocoll's GENTAMICIN SURGICAL IMPLANT...
Published Monday, January 01 2007
Collatamp G's current media exposure and advertising campaigns: (April, 2009) Collatamp G appears in feature-length profile of St. Thomas Elgin General Hospital (April, 2009) Collatamp G's advertisement in the Canadian Journal of Surgery (March, 2009, page 7) Collatamp G's current advertising campaign...
